{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:40:40Z","timestamp":1725410440799},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T00:00:00Z","timestamp":1306454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s12032-011-9986-9","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T15:13:34Z","timestamp":1306422814000},"page":"2021-2026","source":"Crossref","is-referenced-by-count":8,"title":["Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature"],"prefix":"10.1007","volume":"29","author":[{"given":"Mutlu","family":"Dogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye Yildirim","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulku Yalcintas","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfi","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gungor","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurullah","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necati","family":"Alkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikri","family":"Icli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,27]]},"reference":[{"key":"9986_CR1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"9986_CR2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"HK Matthew","year":"1999","unstructured":"Matthew HK, Mayer RJ. Carcinoid tumors. N Engl J Med. 1999;340:858\u201368.","journal-title":"N Engl J Med"},{"key":"9986_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","volume":"332","author":"C Larsson","year":"1988","unstructured":"Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988;332:85\u20137.","journal-title":"Nature"},{"key":"9986_CR4","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/hmg\/6.13.2285","volume":"6","author":"LV Debelenko","year":"1997","unstructured":"Debelenko LV, et al. Identification of MEN-1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet. 1997;6:2285\u201390.","journal-title":"Hum Mol Genet"},{"key":"9986_CR5","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1210\/jc.81.9.3164","volume":"81","author":"O Jakobovitz","year":"1996","unstructured":"Jakobovitz O, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab. 1996;81:3164\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9986_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1294.002","volume":"1014","author":"G Kl\u00f6ppel","year":"2004","unstructured":"Kl\u00f6ppel G, Peren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13\u201327.","journal-title":"Ann N Y Acad Sci"},{"key":"9986_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1196\/annals.1294.021","volume":"1014","author":"A Peren","year":"2004","unstructured":"Peren A, Komminoth P, Heitz PU. Molecular Genetics of Gastroenteropancreatic endocrine tumors. Ann N Y Acad Sci. 2004;1014:199\u2013208.","journal-title":"Ann N Y Acad Sci"},{"key":"9986_CR8","first-page":"1721","volume-title":"Cancer principles and practice of oncology","author":"GM Doherty","year":"2008","unstructured":"Doherty GM. Carcinoid tumors and the carcinoid syndrome. In: De Vita Jr VT, Hellman TS, Rosenberg SA, editors. Cancer principles and practice of oncology. 8th ed. Philedelphia: Lippincott Williams & Wilkins; 2008. p. 1721\u20134.","edition":"8"},{"key":"9986_CR9","first-page":"517","volume":"22","author":"J Soga","year":"2003","unstructured":"Soga J. Carcinoids, their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res. 2003;22:517\u201330.","journal-title":"J Exp Clin Cancer Res"},{"issue":"suppl 2","key":"9986_CR10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/annonc\/10.suppl_2.S9","volume":"10","author":"E Solcia","year":"1999","unstructured":"Solcia E, et al. Clinicopathological profile as a basis for classification of the endocrine tumors of the gastroenteropancreatic tract. Ann Oncol. 1999;10(suppl 2):S9\u201315.","journal-title":"Ann Oncol"},{"key":"9986_CR11","first-page":"353","volume":"16","author":"J Soga","year":"1997","unstructured":"Soga J. Carcinoids of the small intestine: a statistical evaluation of 1,102 cases collected from the literature. J Exp Clin Cancer Res. 1997;16:353\u201363.","journal-title":"J Exp Clin Cancer Res"},{"key":"9986_CR12","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.5858\/2009-0583-RAR.1","volume":"134","author":"N Rekhtman","year":"2010","unstructured":"Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010;134:1628\u201338.","journal-title":"Arch Pathol Lab Med"},{"key":"9986_CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2005.04.1202","volume":"24","author":"H Asamura","year":"2006","unstructured":"Asamura H, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 2006;24:70\u20136.","journal-title":"J Clin Oncol"},{"key":"9986_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0169-5002(02)00099-5","volume":"37","author":"J Mazi\u00e8res","year":"2002","unstructured":"Mazi\u00e8res J, et al. Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer. 2002;37:287\u201392.","journal-title":"Lung Cancer"},{"key":"9986_CR15","doi-asserted-by":"crossref","unstructured":"de Ara\u00fajo EB, et al. A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours. Appl Radiat Isot. 2009;67:227\u201333. [Epub 2008 Oct 5].","DOI":"10.1016\/j.apradiso.2008.09.009"},{"key":"9986_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000051862","volume":"62","author":"K Oberg","year":"2000","unstructured":"Oberg K. Interferon in the management of neuroendocrine GEP-tumors: a review. Digestion. 2000;62:92\u20137.","journal-title":"Digestion"},{"key":"9986_CR17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1200\/JCO.1989.7.7.865","volume":"7","author":"CG Moertel","year":"1989","unstructured":"Moertel CG, Rubin J, Kvols LK. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol. 1989;7:865\u20138.","journal-title":"J Clin Oncol"},{"key":"9986_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","volume":"68","author":"CG Moertel","year":"1991","unstructured":"Moertel CG, Kvols LK, O\u2019Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227\u201332.","journal-title":"Cancer"},{"key":"9986_CR19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.1984.2.11.1255","volume":"2","author":"PF Engstrom","year":"1984","unstructured":"Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass HO Jr. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol. 1984;2:1255\u20139.","journal-title":"J Clin Oncol"},{"key":"9986_CR20","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1200\/JCO.2005.05.0575","volume":"24","author":"JD Hainsworth","year":"2006","unstructured":"Hainsworth JD, Spigel DR, Litchy S, Greco FA. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. J Clin Oncol. 2006;24:3548\u201354.","journal-title":"J Clin Oncol"},{"key":"9986_CR21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2005.03.6046","volume":"24","author":"MH Kulke","year":"2006","unstructured":"Kulke MH, et al. Phase II study of temozolamide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol. 2006;24:401\u20136.","journal-title":"J Clin Oncol"},{"key":"9986_CR22","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2007.13.6374","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, et al. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol. 2008;26:1316\u201323.","journal-title":"J Clin Oncol"},{"key":"9986_CR23","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","volume":"26","author":"MH Kulke","year":"2008","unstructured":"Kulke MH, et al. Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol. 2008;26:3403\u201310.","journal-title":"J Clin Oncol"},{"key":"9986_CR24","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1200\/JCO.2008.16.7858","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, et al. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low-to intermediate-grade neuroendocrine tumors: results of a phase II study. J Clin Oncol. 2008;26:4311\u20138.","journal-title":"J Clin Oncol"},{"key":"9986_CR25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1245\/s10434-008-0194-6","volume":"16","author":"JT Adler","year":"2009","unstructured":"Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. Ann Surg Oncol. 2009;16:481\u20136.","journal-title":"Ann Surg Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9986-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-9986-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-9986-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T06:51:54Z","timestamp":1637736714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-9986-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,27]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9986"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-9986-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,27]]}}}